ACE and myocardial infarction: A German analysis evaluated that 47% of men and 59% of women received prescriptions for at least three of the four recommended drugs (antiplatelet drugs, β-blockers, ACE inhibitors, lipid-lowering agents) during the time between the initial myocardial infarction and a secondary event [10].